Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 study is assessing bactericidal activity and safety of adding nicotinamide to bedaquiline, pretomanid, and linezolid for drug-susceptible pulmonary tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)
  • Nicotinamide (nicotinamide)
  • Pretomanid (pretomanid)
  • bedaquiline (bedaquiline)

Snippet

Sponsor: Gates Medical Research Institute | Conditions: Drug Susceptible Pulmonary Tuberculosis | Phase 2 | Status: RECRUITING